Evidence map›Paper›PMID 33440922›Full record

ArticleHaematologica2022

Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity.

Amanda Amoah, Anja Keller, Ramiz Emini, Markus Hoenicka, Andreas Liebold, Angelika Vollmer, Karina Eiwen, Karin Soller, Vadim Sakk, Yi Zheng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Ageing, immune fitness and cancer.Nature reviews. Cancer · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Immunological biomarkers of aging.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Amanda AmoahInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm.
Anja KellerInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm.
Ramiz EminiDepartment of Cardiothoracic and Vascular Surgery, Ulm University Hospital, Ulm.
Markus HoenickaDepartment of Cardiothoracic and Vascular Surgery, Ulm University Hospital, Ulm.
Andreas LieboldDepartment of Cardiothoracic and Vascular Surgery, Ulm University Hospital, Ulm.
Angelika VollmerInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm.
Karina EiwenInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm.
Karin SollerInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm.
Vadim SakkInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm.
Yi ZhengCincinnati Children's Hospital Medical Center and University of Cincinnati.
Maria Carolina FlorianInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm.
Hartmut GeigerInstitute of Molecular Medicine, Ulm University, Meyerhofstrasse, 89081 Ulm. hartmut.geiger@uni-ulm.de.
Institute of Molecular Medicine · INUniversity Hospital Ulm · DEUniversität Ulm · DEUniversity of Cincinnati · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we characterize age-related phenotypes of human hematopoietic stem cells (HSC). We report increased frequencies of HSC, hematopoietic progenitor cells and lineage negative cells in the elderly but a decreased frequency of multi-lymphoid progenitors. Aged human HSC further exhibited a delay in initiating division ex vivo though without changes in their division kinetics. The activity of the small RhoGTPase Cdc42 was elevated in aged human hematopoietic cells and we identified a positive correlation between Cdc42 activity and the frequency of HSC upon aging. The frequency of human HSC polar for polarity proteins was, similar to the mouse, decreased upon aging, while inhibition of Cdc42 activity via the specific pharmacological inhibitor of Cdc42 activity, CASIN, resulted in re-polarization of aged human HSC with respect to Cdc42. Elevated activity of Cdc42 in aged HSC thus contributed to age-related changes in HSC. Xenotransplant, using NBSGW mice as recipients, showed elevated chimerism in recipients of aged compared to young HSC. Aged HSC treated with CASIN ex vivo displayed an engraftment profile similar to recipients of young HSC. Taken together, our work reveals strong evidence for a role of elevated Cdc42 activity in driving aging of human HSC, and similar to mice, this presents a likely possibility for attenuation of aging in human HSC.

Indexed as

AgingHematopoietic Stem CellsAgedAnimalsHumansMice

Identifiers

PMID33440922
PMCPMC8804569
OpenAlexW3120379008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.